Skip to main content

Search : Conferences and Meetings

Sort by:

Clear Search
Course image
Linked Courses
401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I, 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II, 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster III, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster I, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III, 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Measurable Residual Disease in Diagnosis and Prognosis: Poster I, 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Measurable Residual Disease in Diagnosis and Prognosis: Poster II, 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Measurable Residual Disease in Diagnosis and Prognosis: Poster III, 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster I, 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster II, 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster III, 621. Lymphomas: Translational Molecular and Genetic: Poster I, 621. Lymphomas: Translational Molecular and Genetic: Poster II, 621. Lymphomas: Translational Molecular and Genetic: Poster III, 622. Lymphomas: Translational Non-Genetic: Poster I, 622. Lymphomas: Translational Non-Genetic: Poster II, 622. Lymphomas: Translational Non-Genetic: Poster III, 623. Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I, 623. Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II, 623. Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III, 624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster I, 624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster II, 624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster III, 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster I, 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster II, 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster III, 626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster I, 626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster II, 626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster III, 627. Aggressive Lymphomas: Targeted and Pharmacologic Therapies: Poster I, 627. Aggressive Lymphomas: Targeted and Pharmacologic Therapies: Poster II, 627. Aggressive Lymphomas: Targeted and Pharmacologic Therapies: Poster III, 628. Aggressive Lymphomas: Cellular Therapies: Poster I, 628. Aggressive Lymphomas: Cellular Therapies: Poster II, 628. Aggressive Lymphomas: Cellular Therapies: Poster III, 629. Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Poster I, 629. Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Poster II, 629. Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Poster III, 641. Chronic Lymphocytic Leukemia: Basic and Translational: Poster I, 641. Chronic Lymphocytic Leukemia: Basic and Translational: Poster II, 641. Chronic Lymphocytic Leukemia: Basic and Translational: Poster III, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundle - Lymphoid Malignancies
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster II, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster I, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster II, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster III, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster I, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster II, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster I, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster II, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III, 619. Acute Myeloid Leukemias: Disease Burden and Measurable Residual Disease in Prognosis and Treatment: Poster I, 619. Acute Myeloid Leukemias: Disease Burden and Measurable Residual Disease in Prognosis and Treatment: Poster II, 619. Acute Myeloid Leukemias: Disease Burden and Measurable Residual Disease in Prognosis and Treatment: Poster III, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster II, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III, 636. Myelodysplastic Syndromes: Basic and Translational: Poster I, 636. Myelodysplastic Syndromes: Basic and Translational: Poster II, 636. Myelodysplastic Syndromes: Basic and Translational: Poster III, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster I, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster III, 908. Outcomes Research: Myeloid Malignancies: Poster I, 908. Outcomes Research: Myeloid Malignancies: Poster II, 908. Outcomes Research: Myeloid Malignancies: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundle Myeloid Malignancies
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 602. Myeloid Oncogenesis: Basic: Poster I, 602. Myeloid Oncogenesis: Basic: Poster II, 602. Myeloid Oncogenesis: Basic: Poster III, 603. Lymphoid Oncogenesis: Basic: Poster I, 603. Lymphoid Oncogenesis: Basic: Poster II, 603. Lymphoid Oncogenesis: Basic: Poster III, 621. Lymphomas: Translational Molecular and Genetic: Poster I, 621. Lymphomas: Translational Molecular and Genetic: Poster II, 621. Lymphomas: Translational Molecular and Genetic: Poster III, 702. CAR-T Cell Therapies: Basic and Translational: Poster I, 702. CAR-T Cell Therapies: Basic and Translational: Poster II, 702. CAR-T Cell Therapies: Basic and Translational: Poster III, 801. Gene Therapies: Poster I, 801. Gene Therapies: Poster II, 801. Gene Therapies: Poster III, 802. Chemical Biology and Experimental Therapeutics: Poster I, 802. Chemical Biology and Experimental Therapeutics: Poster II, 802. Chemical Biology and Experimental Therapeutics: Poster III, 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster I, 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster II, 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundle Omics & Emerging Technologies
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
301. Platelets and Megakaryocytes: Basic and Translational: Poster I, 301. Platelets and Megakaryocytes: Basic and Translational: Poster II, 301. Platelets and Megakaryocytes: Basic and Translational: Poster III, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster I, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster II, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster III, 322. Hemophilia A and B: Clinical and Epidemiological: Poster I, 322. Hemophilia A and B: Clinical and Epidemiological: Poster II, 322. Hemophilia A and B: Clinical and Epidemiological: Poster III, 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I, 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II, 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster III, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III, 401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster I, 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster II, 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster III, 330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster I, 330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster II, 330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster III, 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster I, 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster II, 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundle Thrombosis and Coagulation
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster II, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster III, 102. Iron Homeostasis and Biology in Physiological and Pathological Conditions: Poster I, 102. Iron Homeostasis and Biology in Physiological and Pathological Conditions: Poster II, 102. Iron Homeostasis and Biology in Physiological and Pathological Conditions: Poster III, 112. Thalassemia and Globin Gene Regulation: Poster I, 112. Thalassemia and Globin Gene Regulation: Poster II, 112. Thalassemia and Globin Gene Regulation: Poster III, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III, 401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundle Erythroid Development & Iron Metabolism
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster I, 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster II, 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster III, 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I, 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II, 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster II, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster III, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster II, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster III, 904. Outcomes Research: Hemoglobinopathies: Poster I, 904. Outcomes Research: Hemoglobinopathies: Poster II, 904. Outcomes Research: Hemoglobinopathies: Poster III, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster I, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster III, 907. Outcomes Research: Plasma Cell Disorders: Poster I, 907. Outcomes Research: Plasma Cell Disorders: Poster II, 907. Outcomes Research: Plasma Cell Disorders: Poster III, 908. Outcomes Research: Myeloid Malignancies: Poster I, 908. Outcomes Research: Myeloid Malignancies: Poster II, 908. Outcomes Research: Myeloid Malignancies: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundle Health Services & Outcomes Research
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
201. Granulocytes, Monocytes, and Macrophages: Poster I, 201. Granulocytes, Monocytes, and Macrophages: Poster II, 201. Granulocytes, Monocytes, and Macrophages: Poster III, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III, 401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 701. Experimental Transplantation: Basic and Translational: Poster I, 701. Experimental Transplantation: Basic and Translational: Poster II, 701. Experimental Transplantation: Basic and Translational: Poster III, 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster I, 703. Cellular Immunotherapies other than CAR-T Cells: Poster II, 703. Cellular Immunotherapies other than CAR-T Cells: Poster III, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster I, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster III, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster II, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster III, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster II, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster III, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundle Immune Regulation & Therapies
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster I, 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster II, 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster III, 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster I, 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster II, 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III, 653. Multiple Myeloma: Clinical and Epidemiological: Poster I, 653. Multiple Myeloma: Clinical and Epidemiological: Poster II, 653. Multiple Myeloma: Clinical and Epidemiological: Poster III, 654. Multiple Myeloma: Pharmacologic Therapies: Poster I, 654. Multiple Myeloma: Pharmacologic Therapies: Poster II, 654. Multiple Myeloma: Pharmacologic Therapies: Poster III, 655. Multiple Myeloma: Cellular Therapies: Poster I, 655. Multiple Myeloma: Cellular Therapies: Poster II, 655. Multiple Myeloma: Cellular Therapies: Poster III, 907. Outcomes Research: Plasma Cell Disorders: Poster I, 907. Outcomes Research: Plasma Cell Disorders: Poster II, 907. Outcomes Research: Plasma Cell Disorders: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2025 Annual Meeting Poster Bundles Myeloma Malignancies
View Detail
12/22/2025 To 12/22/2028
Course image
Linked Courses
Education Program, Marquee Sessions, Scientific Program, Scientific Symposia, Special-Interest Sessions, Spotlight Sessions, Trainee Activities and Services, Oral Abstracts
Conferences and Meetings
2024 Annual Meeting Invited Program + Oral Abstracts
View Detail
12/07/2024 To 12/14/2027
Research - Basic Science Research - Biostatistics Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational
Course image
Linked Courses
Education Program, Marquee Sessions, Scientific Program, Scientific Symposia, Special-Interest Sessions, Spotlight Sessions, Trainee Activities and Services
Conferences and Meetings
2024 Annual Meeting - Invited Program
View Detail
12/07/2024 To 12/14/2027
Level 3 (Subspecialty): Fellows developing general hematology expertise for board certification
Research - Basic Science Research - Biostatistics Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational
Course image
Linked Courses
Marquee Sessions, Scientific Program, Scientific Symposia, Special-Interest Sessions, Spotlight Sessions, Trainee Activities and Services
Conferences and Meetings
2024 Annual Meeting Scientific Program
View Detail
12/07/2024 To 12/14/2027
Artificial intelligence (AI) Machine learning Natural language processing Research - Basic Science Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational